ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

Regional Groups: Why 15 Were Not Among Those Funded; Cancer Regional Studies Review Committee Chartered

July 2, 1982

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Simmonds Succeeds Young As ACS President; Lame-Duck Session Unlikely To Approve Funding Bills

November 8, 2002